Related Experiment Video
Updated: Mar 14, 2026
09:02
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
3.2K
Effective cancer targeting and imaging using macrophage membrane-camouflaged upconversion nanoparticles
Lang Rao1, Zhaobo He1, Qian-Fang Meng1
1Key Laboratory of Artificial Micro- and Nano-Structures of Ministry of Education, School of Physics and Technology, Wuhan University, Wuhan, 430072, People's Republic of China.
Journal of Biomedical Materials Research. Part A
|October 9, 2016
Summary
Researchers developed macrophage membrane-camouflaged upconversion nanoparticles (MM-UCNPs) for effective cancer targeting and in vivo imaging. These biocompatible MM-UCNPs show promise for clinical applications in cancer diagnosis and therapy.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Research
Background:
- Upconversion nanoparticles (UCNPs) offer unique optical properties for biomedical applications.
- Existing UCNPs require improved surface engineering for targeted cancer therapy.
- Macrophage membranes possess inherent cancer-targeting capabilities.
Purpose of the Study:
- To develop a simple and effective method for engineering cancer-targeting UCNPs.
- To create macrophage membrane-camouflaged UCNPs (MM-UCNPs) for enhanced cancer imaging.
- To evaluate the in vivo biocompatibility of the developed MM-UCNPs.
Main Methods:
- Synthetic UCNPs were coated with vesicles derived from natural macrophage membranes.
- The resulting MM-UCNPs were characterized for their targeting and imaging capabilities.
- In vivo biocompatibility was assessed through blood biochemistry, hematology, and histology analyses.
Main Results:
- MM-UCNPs demonstrated effective cancer targeting, leveraging macrophage-cancer cell adhesion.
- Enhanced in vivo cancer imaging was achieved using the MM-UCNPs.
- MM-UCNPs exhibited good in vivo biocompatibility, with no significant adverse effects observed.
Conclusions:
- Biomimetic camouflage of UCNPs with macrophage membranes provides a novel strategy for cancer targeting.
- MM-UCNPs offer a promising platform for advanced cancer diagnosis and therapy.
- This approach represents a significant step towards developing clinically applicable nanoprobes.
